CLEVELAND, Ohio (Oct 21, 2025)—Menopause may take a toll on women physically and emotionally due to declining estrogen levels. For some, the use of hormone therapy has proven valuable in managing bothersome menopause symptoms. A new study suggests that when a woman starts taking hormones makes a major difference in longer term health outcomes. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25.

CLEVELAND, Ohio (Oct 21, 2025)—Despite growing recognition of sex differences in traumatic brain injury (TBI) outcomes, the interaction between hormone transitions–particularly menopause–and brain injury remains significantly underexplored in both research and clinical care. A new study suggests a greater focus on hormone changes when diagnosing and treating TBIs in menopausal women. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25.

CLEVELAND, Ohio (Oct 21, 2025)—Women face a higher risk of developing both cardiovascular disease and Alzheimer’s disease than men. Cardiovascular disease is linked to an increased likelihood of Alzheimer’s disease, especially among women. A new study investigated whether earlier age at menopause influences the association between cardiac function and brain health. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25.

CLEVELAND, Ohio (Oct 21, 2025)—The prevalence of metabolic syndrome, a dangerous and potentially deadly condition, increases with menopause. That’s the result of decreasing estrogen that protects against these metabolic conditions. A new study not only identified the prevalence of metabolic syndrome but also sought to determine its association with the age of natural menopause. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando, October 21-25.

CLEVELAND, Ohio (Oct 21, 2025)—Many women during menopause complain about brain fog, which includes symptoms like forgetfulness, trouble concentrating, and mental fatigue, often due to fluctuating hormone levels. A literature review was conducted to examine published studies that explore the link between structural brain changes during menopause and cognitive, emotional and physiological outcomes. Findings from this review will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25.

CLEVELAND, Ohio (Oct 21, 2025)—Anxiety is a common and significant symptom of menopause and perimenopause, largely due to hormone fluctuations. Numerous studies have focused on the potential benefits of hormone therapy in reducing anxiety. A new systematic review indicates the treatment does not consistently impact anxiety symptoms in midlife women. Results of the review will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando, October 21-25.

CLEVELAND, Ohio (Oct 21, 2025)—Not all healthcare professionals receive the same type of formal education. That may help explain the results of a new study which suggests that provider type and specialty greatly affect whether a woman receives prescription medication treatment for menopause-related care and, if so, what kind of treatment she receives. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25.